Screener
Immunome IMNM PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Immunome’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219425
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $582,693 | $653,482 |
| Prepaid expenses and other current assets | 11,616 | 7,295 |
| Total current assets | 594,309 | 660,777 |
| Property and equipment, net | 17,081 | 14,636 |
| Operating right-of-use assets | 2,828 | 2,978 |
| Restricted cash | 210 | 210 |
| Other long-term assets | 5,364 | 4,587 |
| Total assets | $619,792 | $683,188 |
Item 1. Financial Statements.
FAQ
- What is Immunome's PP&E (net)?
- Immunome (IMNM) reported PP&E (net) of $17.08M in Q1 2026.
- How has Immunome's PP&E (net) changed year-over-year?
- Immunome's PP&E (net) increased by 55.9% year-over-year, from $10.95M to $17.08M.
- What is the long-term trend for Immunome's PP&E (net)?
- Over 5 years (2020 to 2025), Immunome's PP&E (net) has grown at a 57.1% compound annual growth rate (CAGR), from $1.53M to $14.64M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Immunome's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude